Chunghwa Chemical Synthesis & Biotech Company Overview

  • Year Founded
  • 1964

Year Founded

  • Status
  • Public

  • Employees
  • 243

Employees

  • Stock Symbol
  • 1762

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.82
  • (As of Friday Closing)

Chunghwa Chemical Synthesis & Biotech Company General Information

Description

Chunghwa Chemical Synthesis & Biotech Co Ltd is engaged in the research, development, manufacturing, and sales of pharmaceutical products. Geographically, it derives a majority of its revenue from the United States and also has a presence in Taiwan. Its product portfolio comprises pain management, antifungal, immunosuppressant, oncology, Cardiovascular, Peptide Drugs, and Others.

Contact Information

Website
www.ccsb.com.tw
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 1 Tung-Hsing Street
  • New Taipei City, Shu-Lin District 238-50
  • Taiwan
+886 02
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
TAI
Corporate Office
  • 1 Tung-Hsing Street
  • New Taipei City, Shu-Lin District 238-50
  • Taiwan
+886 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Chunghwa Chemical Synthesis & Biotech Company Stock Performance

As of 20-Nov-2026, Chunghwa Chemical Synthesis & Biotech Company’s stock price is $0.82. Its current market cap is $63.4M with 76.9M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.82 $0.88 $0.77 - $1.42 $63.4M 76.9M 94.3K -$0.02

Chunghwa Chemical Synthesis & Biotech Company Financials Summary

As of 30-Sep-2026, Chunghwa Chemical Synthesis & Biotech Company has a trailing 12-month revenue of $31.6M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 96,230 77,990 104,672 174,834
Revenue 31,595 25,801 41,987 66,985
EBITDA 5,969 (1,647) 8,517 17,294
Net Income (955) (7,817) 1,653 8,505
Total Assets 132,841 138,051 144,835 168,304
Total Debt 20,551 25,768 26,097 39,349
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Chunghwa Chemical Synthesis & Biotech Company Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Chunghwa Chemical Synthesis & Biotech Company‘s full profile, request access.

Request a free trial

Chunghwa Chemical Synthesis & Biotech Company Patents

Chunghwa Chemical Synthesis & Biotech Company Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12552751-B2 Crystal forms a, b, c, d, e, f and g of selumetinib sulfate and preparation methods thereof Active 01-Jun-2023
US-20240400519-A1 Crystal forms a, b, c, d, e, f and g of selumetinib sulfate and preparation methods thereof Active 01-Jun-2023
US-12479882-B2 Preparation method of setmelanotide by cyclization of disulfide bond in solid phase Active 15-Dec-2022
US-20240199685-A1 Preparation method of setmelanotide by cyclization of disulfide bond in solid phase Active 15-Dec-2022
US-12006324-B1 Preparation method of trilaciclib and precursors of trilaciclib Active 15-Dec-2022 C07D487/14
To view Chunghwa Chemical Synthesis & Biotech Company’s complete patent history, request access »

Chunghwa Chemical Synthesis & Biotech Company Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Chunghwa Chemical Synthesis & Biotech Company Investments (1)

Chunghwa Chemical Synthesis & Biotech Company’s most recent deal was a Joint Venture with Joint Venture (Chunghwa Chemical Synthesis & Biotech Company / BioDuro-Sundia). The deal was made on 03-Mar-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Joint Venture (Chunghwa Chemical Synthesis & Biotech Company / BioDuro-Sundia) 03-Mar-2026 Joint Venture Drug Discovery
To view Chunghwa Chemical Synthesis & Biotech Company’s complete investments history, request access »

Chunghwa Chemical Synthesis & Biotech Company ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Chunghwa Chemical Synthesis & Biotech Company’s complete esg history, request access »

Chunghwa Chemical Synthesis & Biotech Company FAQs

  • When was Chunghwa Chemical Synthesis & Biotech Company founded?

    Chunghwa Chemical Synthesis & Biotech Company was founded in 1964.

  • Where is Chunghwa Chemical Synthesis & Biotech Company headquartered?

    Chunghwa Chemical Synthesis & Biotech Company is headquartered in New Taipei City, Taiwan.

  • What is the size of Chunghwa Chemical Synthesis & Biotech Company?

    Chunghwa Chemical Synthesis & Biotech Company has 243 total employees.

  • What industry is Chunghwa Chemical Synthesis & Biotech Company in?

    Chunghwa Chemical Synthesis & Biotech Company’s primary industry is Biotechnology.

  • Is Chunghwa Chemical Synthesis & Biotech Company a private or public company?

    Chunghwa Chemical Synthesis & Biotech Company is a Public company.

  • What is Chunghwa Chemical Synthesis & Biotech Company’s stock symbol?

    The ticker symbol for Chunghwa Chemical Synthesis & Biotech Company is 1762.

  • What is the current stock price of Chunghwa Chemical Synthesis & Biotech Company?

    As of 20-Nov-2026 the stock price of Chunghwa Chemical Synthesis & Biotech Company is $0.82.

  • What is the current market cap of Chunghwa Chemical Synthesis & Biotech Company?

    The current market capitalization of Chunghwa Chemical Synthesis & Biotech Company is $63.4M.

  • What is Chunghwa Chemical Synthesis & Biotech Company’s current revenue?

    The trailing twelve month revenue for Chunghwa Chemical Synthesis & Biotech Company is $31.6M.

  • What is Chunghwa Chemical Synthesis & Biotech Company’s annual earnings per share (EPS)?

    Chunghwa Chemical Synthesis & Biotech Company’s EPS for 12 months was -$0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process